Basic Cardiovascular Sciences  /  GS02. Heart Failure and Cardiomyopathy  /  Hydrogen Sulfide and HFpEF
Logo

American Heart Association

  65
  0

Final ID:

Hydrogen Sulfide and HFpEF

  • Lefer, David  ( Cedars-Sinai Medical Center , Los Angeles , California , United States )
    • Author Disclosures:
    David Lefer: DO have relevant financial relationships ; Consultant:Gordian Biotechnology:Active (exists now) ; Consultant:Sulfagenix, Inc.:Active (exists now)
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

GS02. Heart Failure and Cardiomyopathy

Monday, 07/22/2024 , 03:15PM - 04:30PM

General Session

More abstracts on this topic:
MYZAP, m6 methylation and Cardiomyopathy

Accornero Federica

GRK2 and diabetic cardiomyopathy – female mice

Schumacher Sarah

More abstracts from these authors:
Weight Loss Independent Benefits of the GLP-1 Receptor Agonist Semaglutide in Cardiometabolic HFpEF

Elbatreek Mahmoud, Li Zhen, Yu Xiaoman, Arkat Silpa, Shah Sanjiv, Goodchild Traci, Lefer David

Renoprotection Drives Cardioprotection in Heart Failure

Lefer David

You have to be authorized to contact abstract author. Please, Login
Not Available